Cargando…

Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III

It has been reported that younger patients with non-small cell lung cancer (NSCLC) tend to have a better prognosis. Yet, few studies have focused on the clinicopathological characteristics and prognosis of young small cell lung cancer (SCLC), especially for patients with age < 50. In our study, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haiyong, Zhang, Jingze, Shi, Fang, Zhang, Chenyue, Jiao, Qinghua, Zhu, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471022/ https://www.ncbi.nlm.nih.gov/pubmed/28432275 http://dx.doi.org/10.18632/oncotarget.16823

Ejemplares similares

Incorporating the Number of PLN into the AJCC Stage Could Better Predict the Survival for Patients with NSCLC: A Large Population-Based Study
por: Shang, Xiaoling, et al.
Publicado: (2020)

AJCC cancer staging manual
Publicado: (1998)

Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients
por: Mactier, Swetlana, et al.
Publicado: (2014)

Surgery as a Potential Treatment Option for Patients With Stage III Small-Cell Lung Cancer: A Propensity Score Matching Analysis
por: Zhang, Chenyue, et al.
Publicado: (2019)

A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study
por: Shang, Xiaoling, et al.
Publicado: (2020)

The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III
por: Shu, Ping, et al.
Publicado: (2017)

Better survival in PMRT of female breast cancer patients with >5 negative lymph nodes: A population-based study
por: Wang, Haiyong, et al.
Publicado: (2017)

Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types
por: Zhang, Chenyue, et al.
Publicado: (2020)

Survival analysis following resection of AJCC stage III gallbladder carcinoma based on different combinations of T and N stages
por: Hwang, Kyoung-Yeon, et al.
Publicado: (2015)

Retinoblastoma Survival Following Primary Enucleation by AJCC Staging
por: Zhao, Junyang, et al.
Publicado: (2021)

Comparation between novel online models and the AJCC 8th TNM staging system in predicting cancer-specific and overall survival of small cell lung cancer
por: Liu, Meiyun, et al.
Publicado: (2023)

The prognosis analysis of different metastasis pattern in patients with different breast cancer subtypes: a SEER based study
por: Wang, Haiyong, et al.
Publicado: (2016)

Male patients with TERT mutation may be more likely to benefit from immunotherapy, especially for melanoma
por: Li, Jia, et al.
Publicado: (2020)

Genetic alternations and immune characteristics in patients with small cell lung cancer
por: Zhang, Chenyue, et al.
Publicado: (2021)

Intratumor heterogeneity is associated with less CD8(+) T cell infiltration and worse survival in patients with small cell lung cancer
por: Zhang, Chenyue, et al.
Publicado: (2022)

The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system
por: Wang, Sheng-Ye, et al.
Publicado: (2013)

A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden
por: Isaksson, Karolin, et al.
Publicado: (2019)

Disease-Specific Survival of AJCC 8th Stage II Gastric Cancer Patients After D2 Gastrectomy
por: Zheng, Xiaohao, et al.
Publicado: (2021)

Discriminatory Ability and Clinical Utility of the AJCC7 and AJCC8 Staging Systems for Breast Cancer in a Middle-Income Setting
por: Song, Chin-Vern, et al.
Publicado: (2023)

Impact of esophageal cancer staging on overall survival and disease-free survival based on the 2010 AJCC classification by lymph nodes
por: Li, Qun, et al.
Publicado: (2013)

AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer
por: He, Jiehua, et al.
Publicado: (2020)

Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients
por: Kaufman, Kimberley L., et al.
Publicado: (2014)

Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer
por: Kang, Huapyong, et al.
Publicado: (2022)

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
por: Yang, Yaewon, et al.
Publicado: (2016)

FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma
por: Liu, Xuling, et al.
Publicado: (2019)

Surgical intervention may be a therapeutic option for NSCLC patients with AJCC stage IV: a large population-based study
por: Wang, Haiyong, et al.
Publicado: (2018)

Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions
por: Zhang, Chenyue, et al.
Publicado: (2023)

Is AJCC/UICC Staging Still Appropriate for Head and Neck Cancers in Developing Countries?
por: Fagan, Johannes J., et al.
Publicado: (2020)

AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN
por: Fan, Zhiyao, et al.
Publicado: (2019)

A Substage Increase in The AJCC Classification System Improves Prognostic Prediction in Stage III Gastric Cancer With Insufficient Lymph Nodes Removed
por: Zhao, Ri-Sheng, et al.
Publicado: (2021)

The updated AJCC/TNM staging system (8(th) edition) for oral tongue cancer
por: Kim, Kyubo, et al.
Publicado: (2019)

Young male breast cancer, a small crowd, the survival, and prognosis?: A population-based study
por: Li, Naikun, et al.
Publicado: (2018)

Neoadjuvant chemotherapy remodels the tumor immune microenvironment by increasing activated and cytotoxic T cell, decreasing B cells and macrophages in small cell lung cancer
por: Shang, Xiaoling, et al.
Publicado: (2023)

Use of S-100B to Evaluate Therapy Effects during Bevacizumab Induction Treatment in AJCC Stage III Melanoma
por: Kruijff, S., et al.
Publicado: (2011)

Comparison of a Tumor-Ratio–Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer
por: Zhang, Miaoquan, et al.
Publicado: (2021)

Evaluation of 7th Edition of AJCC Staging System for Nasopharyngeal Carcinoma
por: Ren, YuFeng, et al.
Publicado: (2017)

Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I‐II gastric cancer after curative gastrectomy
por: Ding, Peng, et al.
Publicado: (2019)

The Integration of the Pre-Treatment Neutrophil-to-Lymphocyte Ratio in the Eighth Edition of the AJCC Staging System for Nasopharynx Cancer
por: Liang, Zhong-Guo, et al.
Publicado: (2021)

Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma
por: Cheng, Chih H, et al.
Publicado: (2011)

Impact of Tumor Grade on Prognosis in Pancreatic Cancer: Should We Include Grade in AJCC Staging?
por: Wasif, Nabil, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_te698861ue46v4m0t5f04tukv8